O'Neil John J, Tchipashvili Vaja, Parent Richard J, Ugochukwu Obinna, Chandra Gaurav, Koulmanda Maria, Ko Dicken, Kawai Tatsuo
Joslin Diabetes Center, Boston, MA, USA.
Cell Transplant. 2003;12(8):883-90. doi: 10.3727/000000003771000110.
Recent advances in islet cell transplantation have led to insulin independence in a majority of islet transplant recipients. However, there exists a need to overcome the shortage of donor tissue and the necessity for life-long immunosuppression. Preclinical studies in large animal models are necessary to evaluate the safety and efficacy of alternative approaches for clinical islet transplantation. The nonhuman primate serves as an appropriate animal model for such investigations; however, a major impediment in performing such preclinical research has been the difficulty in isolating islets of sufficient quantity and quality. The current study describes a simple and cost-effective method to isolate nonhuman primate islets to support preclinical islet transplantation research. The results of islet isolations from 54 cynomolgus monkeys and 4 baboons are reported. The pancreas was infused with Liberase HI and subjected to static digestion. The digested tissue was shaken, filtered through a mesh screen, applied to a discontinuous gradient, and centrifuged in much the same manner as with conventional rodent islet isolations. Islets were collected from the two interfaces, washed, and transplanted. Following purification, cynomolgus monkey islet isolation yields were 50,100 +/- 3120 IE total or 8760 +/- 420 IE/g pancreas with the percent purity and viability of 90.8 +/- 0.9 and 90.7 +/- 0.7, respectively. Total insulin content of the isolated islets was 405 +/- 53 microg insulin with DNA content being and 976 +/- 117 microg DNA, corresponding to a ratio of 0.57 microg insulin/microg DNA. STZ-induced diabetes was reversed in both mouse and nonhuman primate recipients, which possessed significant levels of c-peptide following transplantation and well-granulated islet grafts. The technique yields sufficient numbers of pure and viable islets to support preclinical research to develop improved strategies to prevent the immune destruction of the transplanted islet graft.
胰岛细胞移植的最新进展已使大多数胰岛移植受者实现了胰岛素自主分泌。然而,仍需克服供体组织短缺以及终身免疫抑制的必要性等问题。在大型动物模型中进行临床前研究对于评估临床胰岛移植替代方法的安全性和有效性至关重要。非人灵长类动物是进行此类研究的合适动物模型;然而,开展此类临床前研究的一个主要障碍是难以分离出足够数量和质量的胰岛。本研究描述了一种简单且经济高效的方法来分离非人灵长类动物胰岛,以支持临床前胰岛移植研究。报告了从54只食蟹猴和4只狒狒中分离胰岛的结果。向胰腺注入 Liberase HI 并进行静态消化。将消化后的组织振荡,通过筛网过滤,应用于不连续梯度,并以与传统啮齿动物胰岛分离大致相同的方式进行离心。从两个界面收集胰岛,洗涤后进行移植。纯化后,食蟹猴胰岛分离产量为总计50100±3120 IE 或8760±420 IE/g胰腺,纯度百分比和活力分别为90.8±0.9和90.7±0.7。分离出的胰岛总胰岛素含量为405±53μg胰岛素,DNA含量为976±117μg DNA,对应胰岛素与DNA的比率为0.57μg胰岛素/μg DNA。链脲佐菌素诱导的糖尿病在小鼠和非人灵长类动物受体中均得到逆转,移植后它们具有显著水平的C肽且胰岛移植物有良好的颗粒组织。该技术可产生足够数量的纯净且有活力的胰岛,以支持临床前研究,从而开发出改进策略来防止移植的胰岛移植物发生免疫破坏。